Priority for Pediatric Cures Act
In committeeWhat this bill is intended to do
Congress.gov hasn't published an official summary for this bill yet, it usually appears after the bill advances out of committee. The full text is linked below.
Latest action
Sep 14, 2026Referred to the House Committee on Energy and Commerce.
C68
Graded by The Quiet Ledger
The bill aims to amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products. It involves a straightforward amendment by striking a specific paragraph, with no additional provisions or funding mechanisms included.
Category gradesMembers of The Quiet Ledger see the full per-category breakdown of how this bill was graded.